Skip to main content
Veterinary Medicines

Aftovaxpur DOE (60) O1 BFS + SAT2 Saudi Arabia

Authorised
  • Foot-and-mouth disease virus, serotype O, strain O1 BFS, Inactivated
  • Foot-and-mouth disease virus, serotype SAT2, strain Saudi Arabia, Inactivated

Identifikacija zdravila

Ime zdravila:
Aftovaxpur DOE (60) O1 BFS + SAT2 Saudi Arabia
Učinkovina:
Pot uporabe:
  • intramuskularna uporaba
  • Subkutana uporaba

Podatki o zdravilu

Učinkovina / Jakost:
  • Na voljo samo v English
    Presentation_strength:≥ 6 PD50 Reference:Hse Index:0
  • Na voljo samo v English
    Presentation_strength:≥ 6 PD50 Index:11
Farmacevtska oblika:
  • Emulzija za injiciranje
Withdrawal period by route of administration:
  • Intramuscular use
    • govedo
      • Not applicable
        0
        day
    • Sheep
      • Not applicable
        0
        day
    • Pig
      • Not applicable
        0
        day
  • Subcutaneous use
    • govedo
      • Not applicable
        0
        day
    • Sheep
      • Not applicable
        0
        day
    • Pig
      • Not applicable
        0
        day
Anatomsko-terapevtsko-kemična veterinarska oznaka (ATCvet):
  • QI02AA04
Status dovoljenja:
  • Valid
Authorised in:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Opis ovojnine:

Dodatne informacije

Vrsta postopka za pridobitev dovoljenja:
Imetnik dovoljenja za promet z zdravilom:
  • Boehringer Ingelheim Vetmedica GmbH
Izdano dovoljenje za promet z zdravilom:
Proizvodna mesta, odgovorna za sproščanje serij:
  • Boehringer Ingelheim Animal Health France
Država izdaje dovoljenja:
Ta podatek za to zdravilo ni na voljo.
Pristojni organ:
  • European Commission
Številka dovoljenja :
Ta podatek za to zdravilo ni na voljo.
Datum spremembe statusa dovoljenja:

Dokumenti

Combined File of all Documents

Published:
Bulgarian (PDF)
Download

Combined File of all Documents

Published:
Czech (PDF)
Download

Combined File of all Documents

Published:
Danish (PDF)
Download

Combined File of all Documents

Published:
German (PDF)
Download

Combined File of all Documents

Published:
Greek (PDF)
Download

Combined File of all Documents

Published:
English (PDF)
Download

Combined File of all Documents

Published:
Spanish (PDF)
Download

Combined File of all Documents

Published:
Estonian (PDF)
Download

Combined File of all Documents

Published:
Finnish (PDF)
Download

Combined File of all Documents

Published:
French (PDF)
Download

Combined File of all Documents

Published:
Croatian (PDF)
Download

Combined File of all Documents

Published:
Hungarian (PDF)
Download

Combined File of all Documents

Published:
Icelandic (PDF)
Download

Combined File of all Documents

Published:
Italian (PDF)
Download

Combined File of all Documents

Published:
Lithuanian (PDF)
Download

Combined File of all Documents

Published:
Latvian (PDF)
Download

Combined File of all Documents

Published:
Maltese (PDF)
Download

Combined File of all Documents

Published:
Dutch (PDF)
Download

Combined File of all Documents

Published:
Polish (PDF)
Download

Combined File of all Documents

Published:
Romanian (PDF)
Download

Combined File of all Documents

Published:
Slovak (PDF)
Download

Combined File of all Documents

Published:
slovenščina (PDF)
Download

Combined File of all Documents

Published:
Swedish (PDF)
Download

Combined File of all Documents

Published:
Norwegian (PDF)
Download

Combined File of all Documents

Published:
Portuguese (PDF)
Download

ema-puar-aftovaxpur-v-2292-par-en.pdf

Published:
English (PDF)
Download

ema-puar-aftovaxpur-v-2292-var-ii-0009-en.pdf

Published:
English (PDF)
Download

ema-puar-aftovaxpur-v-2292-var-ii-0001-en.pdf

Published:
English (PDF)
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."